APO Research
Talk to an analyst

APO RESEARCH · REPORT

Azithromycin Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Azithromycin Drug Market Outlook and Growth Opportunities 2026

20 December 2025197 pages

Choose your research edition.

Industry ResearchAzithromycin Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Azithromycin Drug Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Azithromycin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Azithromycin Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Azithromycin Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Azithromycin Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azithromycin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Azithromycin Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Azithromycin Drug market include Teva, Sandoz, Mylan, Pfizer, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation, Zydus Pharmaceuticals, Wockhardt and PLIVA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Azithromycin Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Azithromycin Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Azithromycin Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azithromycin Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Azithromycin Drug Segment by Company

Teva

Sandoz

Mylan

Pfizer

Hainan Poly Pharm

Hainan Hailing Chemipharma Corporation

Zydus Pharmaceuticals

Wockhardt

PLIVA

Lupin

Gland Pharma Limited

CSPC Ouyi Pharmaceutical

CSPC

Aurobindo Pharma

Akorn

Azithromycin Drug Segment by Type

Oral

Injection

Azithromycin Drug Segment by Application

Hospital

Drug Store

Azithromycin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Azithromycin Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Azithromycin Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Azithromycin Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Azithromycin Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azithromycin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azithromycin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azithromycin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Azithromycin Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Azithromycin Drug industry.

Chapter 3: Detailed analysis of Azithromycin Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Azithromycin Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Azithromycin Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Azithromycin Drug Industry Trends Table 2. Azithromycin Drug Industry Drivers Table 3. Azithromycin Drug Industry Opportunities and Challenges Table 4. Azithromycin Drug Industry Restraints Table 5. Global Azithromycin Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Azithromycin Drug Revenue Share by Company (2021-2026) Table 7. Global Azithromycin Drug Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Azithromycin Drug Sales Volume Share by Company (2021-2026) Table 9. Global Azithromycin Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Azithromycin Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Azithromycin Drug Key Company Manufacturing Base & Headquarters Table 12. Global Azithromycin Drug Company, Product Type & Application Table 13. Global Azithromycin Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Azithromycin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Table 18. Significant Companies of Injection Table 19. Global Azithromycin Drug Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Azithromycin Drug Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Azithromycin Drug Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Azithromycin Drug Sales Volume Share by Type (2021-2026) Table 23. Global Azithromycin Drug Sales Volume Share by Type (2027-2032) Table 24. Global Azithromycin Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Azithromycin Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Azithromycin Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Azithromycin Drug Sales Value Share by Type (2021-2026) Table 28. Global Azithromycin Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drug Store Table 31. Global Azithromycin Drug Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Azithromycin Drug Sales Volume by Application (2021-2026) & (W Units) Table 33. Global Azithromycin Drug Sales Volume by Application (2027-2032) & (W Units) Table 34. Global Azithromycin Drug Sales Volume Share by Application (2021-2026) Table 35. Global Azithromycin Drug Sales Volume Share by Application (2027-2032) Table 36. Global Azithromycin Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Azithromycin Drug Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Azithromycin Drug Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Azithromycin Drug Sales Value Share by Application (2021-2026) Table 40. Global Azithromycin Drug Sales Value Share by Application (2027-2032) Table 41. Global Azithromycin Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Azithromycin Drug Sales by Region (2021-2026) & (W Units) Table 43. Global Azithromycin Drug Sales Market Share by Region (2021-2026) Table 44. Global Azithromycin Drug Sales by Region (2027-2032) & (W Units) Table 45. Global Azithromycin Drug Sales Market Share by Region (2027-2032) Table 46. Global Azithromycin Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Azithromycin Drug Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Azithromycin Drug Sales Value Share by Region (2021-2026) Table 49. Global Azithromycin Drug Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Azithromycin Drug Sales Value Share by Region (2027-2032) Table 51. Global Azithromycin Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Azithromycin Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Azithromycin Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Global Azithromycin Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Azithromycin Drug Sales by Country (2021-2026) & (W Units) Table 56. Global Azithromycin Drug Sales Market Share by Country (2021-2026) Table 57. Global Azithromycin Drug Sales by Country (2027-2032) & (W Units) Table 58. Global Azithromycin Drug Sales Market Share by Country (2027-2032) Table 59. Global Azithromycin Drug Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Azithromycin Drug Sales Value Market Share by Country (2021-2026) Table 61. Global Azithromycin Drug Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Azithromycin Drug Sales Value Market Share by Country (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Azithromycin Drug Product Portfolio Table 67. Teva Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sandoz Azithromycin Drug Product Portfolio Table 72. Sandoz Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Mylan Azithromycin Drug Product Portfolio Table 77. Mylan Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Azithromycin Drug Product Portfolio Table 82. Pfizer Recent Development Table 83. Hainan Poly Pharm Company Information Table 84. Hainan Poly Pharm Business Overview Table 85. Hainan Poly Pharm Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hainan Poly Pharm Azithromycin Drug Product Portfolio Table 87. Hainan Poly Pharm Recent Development Table 88. Hainan Hailing Chemipharma Corporation Company Information Table 89. Hainan Hailing Chemipharma Corporation Business Overview Table 90. Hainan Hailing Chemipharma Corporation Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hainan Hailing Chemipharma Corporation Azithromycin Drug Product Portfolio Table 92. Hainan Hailing Chemipharma Corporation Recent Development Table 93. Zydus Pharmaceuticals Company Information Table 94. Zydus Pharmaceuticals Business Overview Table 95. Zydus Pharmaceuticals Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Zydus Pharmaceuticals Azithromycin Drug Product Portfolio Table 97. Zydus Pharmaceuticals Recent Development Table 98. Wockhardt Company Information Table 99. Wockhardt Business Overview Table 100. Wockhardt Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Wockhardt Azithromycin Drug Product Portfolio Table 102. Wockhardt Recent Development Table 103. PLIVA Company Information Table 104. PLIVA Business Overview Table 105. PLIVA Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. PLIVA Azithromycin Drug Product Portfolio Table 107. PLIVA Recent Development Table 108. Lupin Company Information Table 109. Lupin Business Overview Table 110. Lupin Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Lupin Azithromycin Drug Product Portfolio Table 112. Lupin Recent Development Table 113. Gland Pharma Limited Company Information Table 114. Gland Pharma Limited Business Overview Table 115. Gland Pharma Limited Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Gland Pharma Limited Azithromycin Drug Product Portfolio Table 117. Gland Pharma Limited Recent Development Table 118. CSPC Ouyi Pharmaceutical Company Information Table 119. CSPC Ouyi Pharmaceutical Business Overview Table 120. CSPC Ouyi Pharmaceutical Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. CSPC Ouyi Pharmaceutical Azithromycin Drug Product Portfolio Table 122. CSPC Ouyi Pharmaceutical Recent Development Table 123. CSPC Company Information Table 124. CSPC Business Overview Table 125. CSPC Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. CSPC Azithromycin Drug Product Portfolio Table 127. CSPC Recent Development Table 128. Aurobindo Pharma Company Information Table 129. Aurobindo Pharma Business Overview Table 130. Aurobindo Pharma Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Aurobindo Pharma Azithromycin Drug Product Portfolio Table 132. Aurobindo Pharma Recent Development Table 133. Akorn Company Information Table 134. Akorn Business Overview Table 135. Akorn Azithromycin Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Akorn Azithromycin Drug Product Portfolio Table 137. Akorn Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Azithromycin Drug Distributors List Table 141. Azithromycin Drug Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Azithromycin Drug Product Image Figure 2. Global Azithromycin Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azithromycin Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Azithromycin Drug Sales (2021-2032) & (W Units) Figure 5. Global Azithromycin Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Azithromycin Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Image Figure 10. Injection Image Figure 11. Global Azithromycin Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Azithromycin Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Azithromycin Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Azithromycin Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Azithromycin Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Azithromycin Drug Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drug Store Image Figure 19. Global Azithromycin Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Azithromycin Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Azithromycin Drug Sales Volume Share by Application (2021-2032) Figure 22. Global Azithromycin Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Azithromycin Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Azithromycin Drug Sales Value Share by Application (2021-2032) Figure 25. Global Azithromycin Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 26. Global Azithromycin Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Azithromycin Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Azithromycin Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Azithromycin Drug Sales Value (2021-2032) & (US$ Million) Figure 30. North America Azithromycin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Azithromycin Drug Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Azithromycin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Azithromycin Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Azithromycin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Azithromycin Drug Sales Value (2021-2032) & (US$ Million) Figure 36. South America Azithromycin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Azithromycin Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Azithromycin Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Azithromycin Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Azithromycin Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Azithromycin Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Azithromycin Drug Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Azithromycin Drug Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • Pfizer
  • Hainan Poly Pharm
  • Hainan Hailing Chemipharma Corporation
  • Zydus Pharmaceuticals
  • Wockhardt
  • PLIVA
  • Lupin
  • Gland Pharma Limited
  • CSPC Ouyi Pharmaceutical
  • CSPC
  • Aurobindo Pharma
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Azithromycin Drug Sales Value (2021-2032)
  4. 1.2.2 Global Azithromycin Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Azithromycin Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Azithromycin Drug Market Dynamics
  1. 2.1 Azithromycin Drug Industry Trends
  2. 2.2 Azithromycin Drug Industry Drivers
  3. 2.3 Azithromycin Drug Industry Opportunities and Challenges
  4. 2.4 Azithromycin Drug Industry Restraints
3 Azithromycin Drug Market by Company
  1. 3.1 Global Azithromycin Drug Company Revenue Ranking in 2025
  2. 3.2 Global Azithromycin Drug Revenue by Company (2021-2026)
  3. 3.3 Global Azithromycin Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Azithromycin Drug Average Price by Company (2021-2026)
  5. 3.5 Global Azithromycin Drug Company Ranking (2024-2026)
  6. 3.6 Global Azithromycin Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Azithromycin Drug Company Product Type and Application
  8. 3.8 Global Azithromycin Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Azithromycin Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Azithromycin Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Azithromycin Drug Market by Type
  1. 4.1 Azithromycin Drug Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Azithromycin Drug Sales Volume by Type
  5. 4.2.1 Global Azithromycin Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Azithromycin Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Azithromycin Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Azithromycin Drug Sales Value by Type
  9. 4.3.1 Global Azithromycin Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Azithromycin Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Azithromycin Drug Sales Value Share by Type (2021-2032)
5 Azithromycin Drug Market by Application
  1. 5.1 Azithromycin Drug Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Azithromycin Drug Sales Volume by Application
  5. 5.2.1 Global Azithromycin Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Azithromycin Drug Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Azithromycin Drug Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Azithromycin Drug Sales Value by Application
  9. 5.3.1 Global Azithromycin Drug Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Azithromycin Drug Sales Value by Application (2021-2032)
  11. 5.3.3 Global Azithromycin Drug Sales Value Share by Application (2021-2032)
6 Azithromycin Drug Regional Sales and Value Analysis
  1. 6.1 Global Azithromycin Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Azithromycin Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Azithromycin Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Azithromycin Drug Sales by Region (2027-2032)
  5. 6.3 Global Azithromycin Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Azithromycin Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Azithromycin Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Azithromycin Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Azithromycin Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Azithromycin Drug Sales Value (2021-2032)
  12. 6.6.2 North America Azithromycin Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Azithromycin Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Azithromycin Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Azithromycin Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Azithromycin Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Azithromycin Drug Sales Value (2021-2032)
  21. 6.9.2 South America Azithromycin Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Azithromycin Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Azithromycin Drug Sales Value Share by Country, 2025 VS 2032
7 Azithromycin Drug Country-level Sales and Value Analysis
  1. 7.1 Global Azithromycin Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Azithromycin Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Azithromycin Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Azithromycin Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Azithromycin Drug Sales by Country (2027-2032)
  6. 7.4 Global Azithromycin Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Azithromycin Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Azithromycin Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Azithromycin Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Azithromycin Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Azithromycin Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Azithromycin Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Azithromycin Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Azithromycin Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Azithromycin Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Azithromycin Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Azithromycin Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Azithromycin Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Azithromycin Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Azithromycin Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Azithromycin Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Azithromycin Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Azithromycin Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Azithromycin Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Azithromycin Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Azithromycin Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Azithromycin Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Azithromycin Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Azithromycin Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Azithromycin Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Azithromycin Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Azithromycin Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Azithromycin Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Azithromycin Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Azithromycin Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Azithromycin Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Azithromycin Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Azithromycin Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Azithromycin Drug Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Azithromycin Drug Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Azithromycin Drug Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Azithromycin Drug Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Hainan Poly Pharm
  26. 8.5.1 Hainan Poly Pharm Company Information
  27. 8.5.2 Hainan Poly Pharm Business Overview
  28. 8.5.3 Hainan Poly Pharm Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hainan Poly Pharm Azithromycin Drug Product Portfolio
  30. 8.5.5 Hainan Poly Pharm Recent Developments
  31. 8.6 Hainan Hailing Chemipharma Corporation
  32. 8.6.1 Hainan Hailing Chemipharma Corporation Company Information
  33. 8.6.2 Hainan Hailing Chemipharma Corporation Business Overview
  34. 8.6.3 Hainan Hailing Chemipharma Corporation Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hainan Hailing Chemipharma Corporation Azithromycin Drug Product Portfolio
  36. 8.6.5 Hainan Hailing Chemipharma Corporation Recent Developments
  37. 8.7 Zydus Pharmaceuticals
  38. 8.7.1 Zydus Pharmaceuticals Company Information
  39. 8.7.2 Zydus Pharmaceuticals Business Overview
  40. 8.7.3 Zydus Pharmaceuticals Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Zydus Pharmaceuticals Azithromycin Drug Product Portfolio
  42. 8.7.5 Zydus Pharmaceuticals Recent Developments
  43. 8.8 Wockhardt
  44. 8.8.1 Wockhardt Company Information
  45. 8.8.2 Wockhardt Business Overview
  46. 8.8.3 Wockhardt Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Wockhardt Azithromycin Drug Product Portfolio
  48. 8.8.5 Wockhardt Recent Developments
  49. 8.9 PLIVA
  50. 8.9.1 PLIVA Company Information
  51. 8.9.2 PLIVA Business Overview
  52. 8.9.3 PLIVA Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 PLIVA Azithromycin Drug Product Portfolio
  54. 8.9.5 PLIVA Recent Developments
  55. 8.10 Lupin
  56. 8.10.1 Lupin Company Information
  57. 8.10.2 Lupin Business Overview
  58. 8.10.3 Lupin Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lupin Azithromycin Drug Product Portfolio
  60. 8.10.5 Lupin Recent Developments
  61. 8.11 Gland Pharma Limited
  62. 8.11.1 Gland Pharma Limited Company Information
  63. 8.11.2 Gland Pharma Limited Business Overview
  64. 8.11.3 Gland Pharma Limited Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Gland Pharma Limited Azithromycin Drug Product Portfolio
  66. 8.11.5 Gland Pharma Limited Recent Developments
  67. 8.12 CSPC Ouyi Pharmaceutical
  68. 8.12.1 CSPC Ouyi Pharmaceutical Company Information
  69. 8.12.2 CSPC Ouyi Pharmaceutical Business Overview
  70. 8.12.3 CSPC Ouyi Pharmaceutical Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CSPC Ouyi Pharmaceutical Azithromycin Drug Product Portfolio
  72. 8.12.5 CSPC Ouyi Pharmaceutical Recent Developments
  73. 8.13 CSPC
  74. 8.13.1 CSPC Company Information
  75. 8.13.2 CSPC Business Overview
  76. 8.13.3 CSPC Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CSPC Azithromycin Drug Product Portfolio
  78. 8.13.5 CSPC Recent Developments
  79. 8.14 Aurobindo Pharma
  80. 8.14.1 Aurobindo Pharma Company Information
  81. 8.14.2 Aurobindo Pharma Business Overview
  82. 8.14.3 Aurobindo Pharma Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Pharma Azithromycin Drug Product Portfolio
  84. 8.14.5 Aurobindo Pharma Recent Developments
  85. 8.15 Akorn
  86. 8.15.1 Akorn Company Information
  87. 8.15.2 Akorn Business Overview
  88. 8.15.3 Akorn Azithromycin Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Akorn Azithromycin Drug Product Portfolio
  90. 8.15.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Azithromycin Drug Value Chain Analysis
  2. 9.1.1 Azithromycin Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Azithromycin Drug Sales Mode & Process
  6. 9.2 Azithromycin Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Azithromycin Drug Distributors
  9. 9.2.3 Azithromycin Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst